# Xilio Therapeutics, Inc.: filings

XLO · Nasdaq · CIK 1840233 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xlo.md) · [Financials](/companies/xlo/financials.md) · [Filings](/companies/xlo/filings.md) · [Insiders](/companies/xlo/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 100, 8-K 65, 3 38, 10-Q 15, SC 13G/A 14, SC 13G 9, SCHEDULE 13G/A 9, CORRESP 8, S-8 8, DEF 14A 7, UPLOAD 7, 424B5 6, SCHEDULE 13G 6, 10-K 5, DEFA14A 5, EFFECT 5, 4/A 4, ARS 4, S-3 4, PRE 14A 3, 10-Q/A 2, D 2, S-1/A 2, S-3/A 2, SC 13D 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 11:40 ET | [10-Q](/filings/0001193125-26-345759.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345759 |
| 2026-08-12 | 11:35 ET | [8-K](/filings/0001193125-26-345753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345753 |
| 2026-06-12 | 20:05 ET | [8-K](/filings/0001193125-26-269358.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269358 |
| 2026-05-12 | 11:40 ET | [10-Q](/filings/0001193125-26-218200.md) | Quarterly report, period 2026-03-31 | 0001193125-26-218200 |
| 2026-05-12 | 11:35 ET | [8-K](/filings/0001193125-26-218194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218194 |
| 2026-04-28 | 21:02 ET | [DEF 14A](/filings/0001193125-26-187642.md) | Proxy statement, period 2026-06-10 | 0001193125-26-187642 |
| 2026-04-16 | 11:35 ET | [8-K](/filings/0001193125-26-157940.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-157940 |
| 2026-03-23 | 11:40 ET | [10-K](/filings/0001193125-26-118550.md) | Annual report, period 2025-12-31 | 0001193125-26-118550 |
| 2026-03-23 | 11:33 ET | [8-K](/filings/0001193125-26-118544.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-118544 |
| 2026-03-12 | 12:34 ET | [8-K](/filings/0001193125-26-103150.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-103150 |
| 2026-03-09 | 12:00 ET | [8-K](/filings/0001193125-26-097603.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097603 |
| 2026-02-24 | 12:30 ET | [8-K](/filings/0001193125-26-065234.md) | 5.07 Shareholder vote results | 0001193125-26-065234 |
| 2026-02-12 | 21:51 ET | [8-K](/filings/0001193125-26-048942.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-048942 |
| 2026-01-26 | 12:30 ET | [DEF 14A](/filings/0001193125-26-021691.md) | Proxy statement, period 2026-02-23 | 0001193125-26-021691 |
| 2026-01-08 | 13:42 ET | [8-K](/filings/0001193125-26-007063.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-007063 |
| 2026-01-05 | 13:30 ET | [8-K](/filings/0001193125-26-001580.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-001580 |
| 2025-11-25 | 21:05 ET | [8-K](/filings/0001193125-25-297165.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-297165 |
| 2025-11-13 | 12:40 ET | [10-Q](/filings/0001193125-25-278837.md) | Quarterly report, period 2025-09-30 | 0001193125-25-278837 |
| 2025-11-13 | 12:35 ET | [8-K](/filings/0001193125-25-278835.md) | 2.02 Results of operations | 0001193125-25-278835 |
| 2025-11-07 | 14:05 ET | [8-K](/filings/0001193125-25-271189.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-271189 |
| 2025-10-20 | 11:39 ET | [DEF 14A](/filings/0001193125-25-243037.md) | Proxy statement, period 2025-11-21 | 0001193125-25-243037 |
| 2025-10-03 | 11:30 ET | [8-K](/filings/0001193125-25-229231.md) | 3.01 Delisting notice | 0001193125-25-229231 |
| 2025-09-09 | 11:35 ET | [8-K](/filings/0001558370-25-011949.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011949 |
| 2025-08-28 | 20:05 ET | [8-K](/filings/0001558370-25-011802.md) | 3.01 Delisting notice | 0001558370-25-011802 |
| 2025-08-14 | 12:08 ET | [10-Q](/filings/0001558370-25-011477.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011477 |
| 2025-08-14 | 11:35 ET | [8-K](/filings/0001558370-25-011473.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011473 |
| 2025-06-12 | 20:30 ET | [8-K](/filings/0001558370-25-008571.md) | 5.07 Shareholder vote results | 0001558370-25-008571 |
| 2025-06-10 | 20:35 ET | [8-K](/filings/0001558370-25-008512.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-008512 |
| 2025-06-03 | 11:38 ET | [8-K](/filings/0001193125-25-133773.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-133773 |
| 2025-06-02 | 10:08 ET | [8-K](/filings/0001193125-25-132710.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132710 |
| 2025-05-08 | 20:31 ET | [10-Q](/filings/0001558370-25-006996.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006996 |
| 2025-05-08 | 11:35 ET | [8-K](/filings/0001558370-25-006852.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006852 |
| 2025-04-28 | 20:30 ET | [DEF 14A](/filings/0001558370-25-005689.md) | Proxy statement, period 2025-06-10 | 0001558370-25-005689 |
| 2025-04-08 | 20:31 ET | [8-K](/filings/0001558370-25-004599.md) | 3.01 Delisting notice | 0001558370-25-004599 |
| 2025-03-11 | 12:54 ET | [8-K](/filings/0001193125-25-051532.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-051532 |
| 2025-03-11 | 12:15 ET | [10-K](/filings/0001558370-25-002640.md) | Annual report, period 2024-12-31 | 0001558370-25-002640 |
| 2025-03-11 | 11:39 ET | [8-K](/filings/0001193125-25-051441.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-051441 |
| 2025-02-12 | 12:36 ET | [8-K](/filings/0001558370-25-000823.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000823 |
| 2025-01-21 | 22:09 ET | [8-K](/filings/0001558370-25-000291.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000291 |
| 2024-12-19 | 12:45 ET | [8-K](/filings/0001558370-24-016372.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016372 |
| 2024-11-07 | 14:25 ET | [10-Q](/filings/0001558370-24-014775.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014775 |
| 2024-11-07 | 14:20 ET | [8-K](/filings/0001558370-24-014773.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-014773 |
| 2024-09-13 | 20:16 ET | [8-K](/filings/0001558370-24-012775.md) | 3.01 Delisting notice | 0001558370-24-012775 |
| 2024-08-08 | 11:51 ET | [10-Q](/filings/0001558370-24-011471.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011471 |
| 2024-08-08 | 11:45 ET | [8-K](/filings/0001558370-24-011470.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011470 |
| 2024-06-17 | 20:06 ET | [8-K](/filings/0001558370-24-009247.md) | 5.07 Shareholder vote results | 0001558370-24-009247 |
| 2024-06-13 | 20:15 ET | [8-K](/filings/0001558370-24-009138.md) | 5.02 Departure or appointment of officers or directors | 0001558370-24-009138 |
| 2024-05-14 | 12:09 ET | [10-Q](/filings/0001558370-24-008068.md) | Quarterly report, period 2024-03-31 | 0001558370-24-008068 |
| 2024-05-14 | 11:45 ET | [8-K](/filings/0001558370-24-008063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-008063 |
| 2024-04-25 | 20:05 ET | [DEF 14A](/filings/0001558370-24-005762.md) | Proxy statement, period 2024-06-13 | 0001558370-24-005762 |

Page 1 of 2. [Older](/companies/xlo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.